CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 65 filers reported holding CATALYST BIOSCIENCES INC in Q4 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $150,000 | +47.1% | 21,978 | +6.1% | 0.01% | +40.0% |
| Q3 2019 | $102,000 | -39.3% | 20,718 | -9.2% | 0.01% | -50.0% |
| Q2 2019 | $168,000 | +5.0% | 22,828 | +16.0% | 0.01% | 0.0% |
| Q1 2019 | $160,000 | +63.3% | 19,678 | +57.9% | 0.01% | +66.7% |
| Q4 2018 | $98,000 | -52.0% | 12,459 | -34.3% | 0.01% | -33.3% |
| Q3 2018 | $204,000 | – | 18,962 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,076,376 | $13,321,000 | 6.97% |
| 22NW, LP | 1,429,242 | $6,189,000 | 1.66% |
| Ghost Tree Capital, LLC | 1,000,000 | $4,330,000 | 1.19% |
| ACUTA CAPITAL PARTNERS, LLC | 685,000 | $2,966,000 | 1.18% |
| Sio Capital Management, LLC | 623,892 | $2,701,000 | 0.67% |
| Parkman Healthcare Partners LLC | 393,449 | $1,704,000 | 0.37% |
| Nantahala Capital Management | 2,531,360 | $10,961,000 | 0.31% |
| AlphaCentric Advisors LLC | 182,500 | $790,000 | 0.22% |
| Ikarian Capital, LLC | 581,200 | $2,518,000 | 0.20% |
| Tibra Equities Europe Ltd | 79,200 | $343,000 | 0.11% |